Transaction · 0001231589-26-000007

MAHON PAUL A

MAHON PAUL A, EVP, GC, reported a transaction classified as withholding at UNITED THERAPEUTICS Corp involving 3906.000000 shares for an estimated $2094084.72. Reported holdings after the transaction were 45172.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

withholdingSEC transaction code FEVP, GC
UTHRUNITED THERAPEUTICS Corp
Filing timeMar 17
Trade dateMar 15, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$540.02
Pre-filing
1mo ago -12.3%1w ago -11.5%1d ago -0.7%
Returns since
7d -1.5%30d +7.5%90d +1.8%180d -4.0%1y -4.0%

UTHR price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
UTHR since 2026-03-17Filed 171 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
withholding
Code F
Identifier
0001231589-26-000007
Common Stock
Transaction date
Mar 15, 2026
Filed Mar 17, 2026, 12:00 AM · 2d delay
Shares
3.90k sh
$53.6k per share
Estimated value
-$209M
Computed from shares × price
Holdings after
45.1k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
-12score
Filing-only score

-12

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP & GENERAL COUNSEL

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.

  2. F2

    Represents the number of shares withheld by United Therapeutics for tax purposes, upon vesting of restricted stock units.

  3. F3

    Shares received upon vesting of performance-based restricted stock units on March 15, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. These restricted stock…

Original filing · 0001231589-26-000007
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

UTHR